In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Flexion Therapeutics, Inc.. Trade Record

NASDAQ:FLXN Flexion Therapeutics, Inc. stock gains 30.91% Exit Jul 31, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart FLXN Jun 19, 2017, priceSeries
About Flexion Therapeutics, Inc.

Flexion Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It lead product candidate includes Zilretta, a late-stage, intra-articular, extended-release investigational steroid treatment that has completed Phase 3 clinical trials for IA therapy for patients with moderate and severe osteoarthritis pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts.

Trade Information
Trade Type
LONG
ReliabilityScore™
99.60
Entry Date
Jun 19, 2017
Entry Price
17.79
Sell Date
Jul 31, 2017
Sell Price
23.29
Net Gain
30.91%
Hold Time
29 Trading Days